Viatris Newsroom

Argus Research Initiates Viatris(VTRS.US) With Hold Rating

Moomoo NewsJan 7 10:31 ET

Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsDec 17, 2024 08:33 ET

Viatris Analyst Ratings

BenzingaDec 6, 2024 09:21 ET

Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Raises Target Price to $14

Moomoo NewsDec 6, 2024 07:31 ET

Viatris Is Maintained at Underweight by Barclays

Dow JonesNov 8, 2024 14:29 ET

Viatris Analyst Ratings

BenzingaNov 8, 2024 14:19 ET

Barclays Maintains Viatris(VTRS.US) With Sell Rating, Raises Target Price to $12

Moomoo NewsNov 8, 2024 06:31 ET

Barclays Maintains Viatris(VTRS.US) With Sell Rating, Maintains Target Price $11

Moomoo NewsNov 6, 2024 03:33 ET

Barclays Maintains Viatris(VTRS.US) With Sell Rating, Maintains Target Price $11

Moomoo NewsOct 28, 2024 05:34 ET

Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsOct 15, 2024 08:31 ET

Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Maintains Target Price $13

Moomoo NewsSep 26, 2024 20:31 ET

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6, 2024 08:42 ET

Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Maintains Target Price $13

Moomoo NewsJul 24, 2024 07:31 ET

Viatris Analyst Ratings

BenzingaJul 19, 2024 08:49 ET

Viatris Analyst Ratings

BenzingaMar 28, 2024 12:24 ET

Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $11

BenzingaNov 22, 2023 12:57 ET

Viatris Analyst Ratings

BenzingaNov 22, 2023 12:52 ET

B of A Securities Downgrades Viatris to Underperform, Announces $9 Price Target

BenzingaOct 23, 2023 07:21 ET

Viatris Analyst Ratings

BenzingaOct 23, 2023 07:20 ET

Piper Sandler Sticks to Their Hold Rating for Viatris (VTRS)

TipRanksAug 8, 2023 08:55 ET